Synaptogenix announces corporate update conference call

New york , july 21, 2022 /prnewswire/ -- synaptogenix, inc. (nasdaq: snpx) ("the company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, today announced that it will hold a corporate update conference call for investors. the call will take place on tuesday, july 26 th at 4:30pm et and will be hosted by the company's chief executive officer, dr. alan tuchman, and its president and chief science officer, dr. daniel alkon.
SNPX Ratings Summary
SNPX Quant Ranking